Several studies have sought to clarify the association between adolescent obesity and psychological distress. Recently, a biological link between leptin resistance and depression has been proposed. The aim of the present study was to examine changes in leptin concentrations as a potential predictor of reduced depression symptoms in obese adolescents during long-term interdisciplinary weight loss therapy. Seventy-five obese adolescents (age: 16.28 ± 2.37 years; BMI: 35.65 ± 4.64 kg/m 2 ) engaged in a long-term interdisciplinary therapy for weight loss. They were evaluated at baseline and after 1 year of treatment for body composition, serum analyses and depression symptomatology. After therapy, body mass BMI, fat mass (% and kg), waist circumference, visceral, subcutaneous and visceral/subcutaneous fat and depression symptoms decreased and lean mass (%) increased significantly. There was an improvement in inflammatory profiles with a significant reduction in leptin and increase in adiponectin. Regression analyses showed that decreased leptin predicted amelioration in depression symptoms independent of age, gender and changes in visceral fat, body mass, fat mass (%) and leptin/adiponectin ratio. These associations appear stronger in girls than boys. The attenuation of hyperleptinemia appears to play an important role in the association between weight loss and depression, particularly in obese girls.
Introduction
Obesity is an inflammatory multifactorial disease that has become a global epidemic reaching high prevalence in both developed and developing countries. The World Health Organization [54] reports that over 1.5 billion people were overweight and more than half a billion were obese worldwide. In Brazil, 50% of the adult population and 30% of adolescents are overweight or obese, which represents a major public health problem [25] .
There are many studies demonstrating strong associations between obesity and depression. It has been demonstrated that obesity increases the risk of poor mental health, including greater levels of unhappiness, pessimism, low positive affect, dissatisfaction with life and suicidal behaviors [3, 5, 16, 26, 37, 46, 48, 49] .
Leptin is an adipokine that is expressed by adipose tissue and thought to play a key role in the neuroendocrine control of energy balance. Recent studies have established that obese individuals frequently present with elevated plasma leptin concentrations, causing a state of hyperleptinemia, in which leptin insensitivity or leptin resistance is likely. There are some important implications of leptin resistance in obesity. It is known that this condition hinders the weight loss process and it is not easily reversed. Previous studies have shown that the leptin resistance seems to be controlled http://dx.doi.org/10.1016/j.peptides.2014.11.010 0196-9781/© 2015 Elsevier Inc. All rights reserved.
only after massive losses of weight and even so, some individuals remains in a hyperleptinemic state [10, 34] .
Importantly, in addition to impair the control of energy balance, the state of hyperleptinemia is related to inflammatory response in obesity [4, 30, 51] and a positive association between pro-inflammatory cytokines and leptin concentrations in obesity and its related comorbidities has been well established in the literature and in previous studies from our group. Leptin has emerged as a key player in the pro-inflammatory process in obesity and metabolic syndrome and is, therefore, considered a pivotal link in obesity-related diseases, enhancing, for example, cardiovascular risks associated with obesity [14, 51] . Moreover, recent findings have shown that in addition to promoting the inflammatory process of obesity, hyperleptinemia impairs the anti-inflammatory effects of adiponectin [10] .
A relationship between inflammatory status in obesity and depression has been proposed [52] . Studies have uncovered a potential biological link between leptin concentrations and depression in older male individuals in the presence of abdominal obesity, raising the possibility that leptin resistance could be important. The authors suggests that, despite increased leptin circulating levels in obesity, leptin resistance due to impaired transport across the blood-brain barrier, reduced function of the leptin receptor and defects in leptin signal transduction, may explain these results [38] . Moreover, in a large epidemiological and longitudinal study, Pasco et al. [45] demonstrated that serum leptin predicted the later development of major depression. However, the relationship between depression and leptin remains inconclusive with studies indicating lower or higher levels of leptin in patients with depression, while others report no association [2, 11, 17, 27, 29] .
In obese adolescents, there have been no studies examining the association between depression and leptinemia. Therefore, research is needed to explore effective treatment methods for improving physical and mental health in the adolescent population and to clarify the mediating processes behind such improvements. The aims of the present study were firstly to examine the effect of an interdisciplinary long-term weight loss therapy on leptinemia and depression; and secondly to examine post-therapy changes in leptin concentrations as a predictor of reduced depression symptoms in obese adolescents.
Methods

Participants
Individuals were initially recruited by advertisement in local media before being medically screened for inclusion in the Federal University of São Paulo Interdisciplinary Obesity Group Program [10] . Seventy-five treatment-seeking obese adolescents (30 boys and 45 girls) with a mean age of 16.28 ± 2.37 years were included (age ranged from 13 to 19). Mean body mass index was 35.65 ± 4.64 kg/m 2 (BMI ≥ 95th [7] ) and postpubertal stage V based on the Tanner and Whitehouse stages [53] . Exclusion criteria were: alteration in exercise electrocardiography; known history of diseases related to the immune system; use of medication and/or dietary supplements that alter metabolism in the 6 months preceding the start of the study; genetic, osteo-muscular, mental or endocrine diseases; current treatment -pharmacological and/or psychotherapeutic -for psychological diseases, such as depression; and prior chronic consumption of alcohol or recreational drugs.
This study was formally approved by the ethical committee of the Federal University of São Paulo (#103310/12) and is a registered Clinical Trial (NCT 0135/7883). All participants and/or their parents gave informed consent and agreed to participate on a voluntary basis. This study was carried out in accordance with the principles of the Declaration of Helsinki. Participants were submitted to anthropometric, body composition, serum analysis and psychological symptom evaluations at baseline and after long-term interdisciplinary therapy (1 year).
Measurements Anthropometric evaluation and body composition
Anthropometric measurements were assessed with individuals standing, wearing light clothing and no shoes. They were weighed on a Filizola scale (São Paulo, SP, Brazil) to the nearest 0.1 kg and height was measured using a wall-mounted Sanny stadiometer (model ES 2030, São Paulo, SP, Brazil) to the nearest 0.5 cm. Body mass index was calculated as body weight divided by height squared. Body composition was estimated by air displacement plethysmography using the BODPOD body composition analyzer (version 1.69; Life Measurement Instruments, Concord, CA) [13] .
Serum analysis
Blood collection was performed after a 12-h overnight fast by venipuncture in the forearm. The plasma was separated and analyzed after collection. Serum concentrations of adiponectin and leptin were measured using a commercially available enzymelinked immunosorbent assay (ELISA) kit from R&D Systems (Minneapolis, MN, USA) according to the manufacturer's instructions. Leptin data were analyzed according to reference values described by Gutin et al. [18] .
Visceral and subcutaneous adiposity measurements
The same physician specialist in imaging diagnostics performed abdominal ultrasonographic measurements of visceral and subcutaneous fat tissues at baseline and after therapy. A 3.5-MHz multifrequency transducer (broad band) was used to reduce the risk of misclassification and the intra-examination coefficient of variation for ultrasound (US) was 0.8%. Subcutaneous fat was defined as the distance between the skin and superficial plane of the rectus abdominal muscle and visceral fat was defined as the distance between the deep plane of the same muscle and the anterior wall of the aorta [47] .
Depression symptoms
Depression symptoms were evaluated using the Beck Depression Inventory (BDI), a 21-item self-report questionnaire which identifies symptoms of depression in the general population. The BDI has been translated into Portuguese and validated in the Brazilian population [9] . Each item presents four statements representing escalating severity of depression symptoms. The instrument assesses the severity of depression with the following standard: no concern (0-11), mild (12) (13) (14) (15) (16) (17) (18) (19) , moderate (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) and severe .
Therapy protocol
The therapy protocol consisted of interdisciplinary group therapy three times per week. The adolescents took part in clinical, nutritional and psychological-based therapy sessions, as well as a supervised physical exercise program.
Clinical therapy
The clinical therapy consisted of individual clinical consultations once a month with an endocrinologist physician. Volunteers attended this meeting accompanied by their parents or guardians. Weight loss and medical test results were discussed.
Nutritional therapy
The nutritional group therapy took place once a week with the goal of improving nutrition education. The main aims were to assist and orient healthy food choices, providing information about the food pyramid, loss diets versus fad diets, food labels, fat-free and low-calorie foods, fats, fast foods, healthy snacks, functional foods, etc. Monthly, participants were given an individual nutrition consultation. Energy intake was set at the levels recommended by the dietary reference intake for subjects with low levels of physical activity and of the same age and gender following a balanced diet [43] . No pharmacotherapies or antioxidants were recommended.
Psychological therapy
The psychological group therapy took place once a week with the aim to discuss and equip the skills to manage emotional issues associated with obesity: binge eating, bulimia nervosa, depression, anxiety, body image, the relationship between food and feelings, stress, family problems, etc. In each psychological session, the consequences for health and the relationship with the cause and maintenance of obesity were debated with the adolescents. Furthermore, the therapy guided the volunteers' ways of dealing with these issues, favoring treatment success. All study volunteers received individual psychological consultations and those who presented greater difficulty dealing with behavioral and/or emotional problems were systematically consulted.
Exercise program
The physical exercise program consisted of supervised aerobic and resistance exercise training three times per week. Participants performed 30 min of aerobic exercise per session (bicycle or treadmill) and about 30 min of resistance exercises based on guidelines from the American College of Sports Medicine [1] . During 2 weeks, all subjects familiarized themselves with the training protocol, before starting the program. The aerobic exercises were conducted at the intensity of effort for the first ventilatory threshold determined by direct gas analysis (50-70% of maximum oxygen uptake) and controlled by a frequency rate, as determined by the results of an initial oxygen uptake test for aerobic exercise. The cardiac frequency was controlled by the physiologists and it was measured with a cardiometer at intervals of 5 min during all training sessions (Polar Model FS1 dark blue).
Statistical analyses
Data were analyzed using STATISTICA 7.0 (StatSoft, Tulsa, OK, USA) and the ˛-level was set at <0.05. Kolmogorov-Smirnov test was used to verify distributional assumptions. Variables with normal distributions are expressed as means ± standard deviation and variables without normal distribution are expressed as medians (minimum − maximum). Comparisons between values at baseline and after therapy and between groups were made using ANOVA two-way for parametric variables and Wilcoxon and Mann-Whitney t-test for non-parametric variables. Correlations between changes ( ) in depression and leptin with the analyzed variables were performed using Pearson's and Spearman's correlations. Simple and multiple linear regression analyses were used to verify the influence of changes in leptinemia on depression symptoms. BMI Z-scores were obtained using EPI INFO Software, version 3.5.3 (CDC, Atlanta, GA, USA).
Results
A total of 75 obese adolescents (30 boys and 45 girls) completed 1 year of therapy with completion of more than 75% of treatment sessions. As can be seen in Table 1 , it was observed in the total sample a significant decrease in body mass, BMI, zBMI and body fat (kg and %) with a corresponding increase in lean mass (%). There were also decreases in waist circumference, visceral fat and visceral/subcutaneous fat ratio. Adiponectin and leptin concentrations, as well as adiponectin/leptin and leptin/adiponectin ratio, were all significantly different from baseline to post therapy. Furthermore, there was a significant decrease in depression symptoms in the total sample.
There were some differences between gender groups. At baseline, boys were higher than girls and had significantly greater values on lean mass (kg and %), visceral fat and visceral/subcutaneous ratio. On the other hand, girls had significantly higher fat mass (%), subcutaneous fat and leptin concentration. After therapy, girls had the same result as the total sample and boys did not have significantly lower visceral/subcutaneous fat ratio. The absolute value of change ( ) was similar between boys and girls on the parameters evaluated, with exception of adiponectin/leptin ratio, for which boys had a significantly greater increase and zBMI on which boys had a greater decrease (Table 1) .
Correlations between leptin and depression with changes in body composition
It was demonstrated that changes in leptin concentrations were positively correlated with changes in body mass, BMI, fat mass (% and kg), visceral fat, subcutaneous fat, leptin/adiponectin ratio and depression symptoms. Moreover, changes in leptin were negatively correlated with changes in adiponectin/leptin ratio and lean mass (%). Considering groups by gender, changes in leptin remained positively correlated in boys with changes in body mass, BMI, subcutaneous fat and leptin/adiponectin ratio and negatively correlated with changes in adiponectin/leptin ratio. In girls, changes in leptin remained positively correlated with changes in body mass, BMI, fat mass (% and kg), subcutaneous fat, leptin/adiponectin ratio and depression symptoms and negatively correlated with changes in lean mass (%) and adiponectin/leptin ratio ( Table 2) .
On examination of psychological symptoms, change in depression scores was correlated with a number of changes in anthropometric and body composition profiles after long-term weight loss therapy. Specifically, positive correlations were observed between depression symptoms and changes in body mass, BMI, fat mass (kg) and subcutaneous fat. Furthermore, changes in depression symptoms were correlated with inflammatory status as indicated by positive correlations with changes in leptin concentrations and leptin/adiponectin ratio. In boys, changes in depression symptoms remained positively correlated only with changes in subcutaneous fat. On the other hand, in girls, the positive correlations remained between changes in depression and changes in body mass, BMI, subcutaneous fat, leptin, leptin/adiponectin ratio. In addition, the negative correlation between changes in depression symptoms and changes in adiponectin/leptin ratio also remained in girls (Table 2) .
Regressions analysis
The simple linear regression analysis demonstrated that changes in leptin were significantly associated with changes in depression symptoms following long-term interdisciplinary therapy (ˇ = 0.37; p = 0.001). When analyzed separately, changes in leptin remained correlated to changes in depression symptoms in girls (ˇ = 0.49; p < 0.001), but not in boys (ˇ = 0.22; p = 0.25) (Fig. 1) .
To strengthen the interpretation of these findings, a multiple regression analysis was performed to assess whether change in leptin concentrations was an independent predictor of change in depression symptoms after controlling for confounding factors. In the subsequent models examined, change in leptin was upheld as a significant predictor of change in depression in the total sample independently of change in visceral fat, body mass, fat mass (%), and leptin/adiponectin ratio. The changes in zBMI scores showed to share with changes in leptin the role as predictor of decreased depressive symptoms in the total sample (Table 3) . However, when the sample was analyzed according to gender groups, leptin remained as an independent predictor of changes in depression symptoms in girls, but not in boys, including the model that considered the zBMI, as can be seen in Table 3 .
Discussion
Individuals with obesity frequently present with a state of hyperleptinemia, indicative of leptin insensitivity or resistance, and recent studies have suggested that leptin may have a role in the relationship between obesity and depression [10, 24] . The present study investigated the role of reduced leptin concentrations during long term interdisciplinary weight loss therapy as a predictor of improved depressive symptoms in obese adolescents.
As stated before, controlling leptinemia is important for restoring the protective effect of this adipokine. Hyperleptinemic state has a strong pathological influence in body weight control and is also associated to the subclinical inflammatory state of obesity, being related to the development of obesity-related diseases, such as cardiovascular diseases, insulin resistance and metabolic syndrome. This condition also impairs the effects of adiponectin, an anti-atherogenic adipokine in obese individuals [4, 34] . However, within normal physiological range, leptin function contributes to neuroendocrine control of energy balance, controlling satiety signals and, in this sense, may be crucial to weight control [15] .
The most important finding of this study was the confirmation of change in leptin as a potential mechanism associating obesity and depression independently of changes in adiposity. In this sample, decreased leptin concentrations after therapy was correlated to decreased depression symptoms and leptin was confirmed as an independent predictor of depression symptoms after controlling for adiposity measures and other confounding factors including gender, age, changes in body mass, fat mass (%), visceral fat and leptin/adiponectin ratio. These results remained in girls, but not in boys when the sample was analyzed separately according to gender. Furthermore, improvement in depression symptoms was correlated with the decrease in the leptin/adiponectin ratio, which is an important indicator of inflammatory status [57] .
Indeed, according to Marazziti et al. [35] , animal model investigations have demonstrated that leptin could have an antidepressant-like efficacy and, although there are high circulating levels of leptin in the obese, they are resistant to its effects. The authors pointed out that this hypothesis is supported by studies using diet-induced obese mice and suggest that, similarly in obese individuals, leptin resistance could underlie depressive symptoms. Accordingly, Yamada et al. [55] suggested that obesity-associated depression in mice might be partly caused to impaired leptin activity in the hippocampus, an important brain region for regulation of the depressive state. The authors highlights that diet induced obesity mice do not exhibit an increase in the number of c-Fos-immunoreactive cells (a neuronal activation marker) in the hippocampus in the response to leptin administration. Differently, control diet mice respond to leptin, increasing the number of c-Fos immunoreactive cells in the hippocampus, which leads to exhibition of antidepressive behaviors. Thus, it is suggested that in diet induced obese mice, the leptin resistance results in a severe depressive state despite hyperleptinemia. This sense, the present investigation provides some support for this hypothesis in human subjects, since demonstrated that the attenuation of leptinemia in obese adolescents could be, at least in part, responsible for improving the mental health status of these individuals.
Furthermore, according to Lu [32] , it can be suggested that leptin modulates hypothalamic-pituitary-adrenal (HPA) axis function at multiple levels and it is one consistent explanation about how leptin can affect mood. Dysregulation of the HPA axis is reported in patients with major depression disorder and seems to play a role in the pathophysiology of the disease [42] .
In agreement, Hryhorczuk et al. [24] concluded from a review of the literature that leptin resistance is a plausible mechanism underlying depression in obesity because leptin resistance appears to affect emotions and mood through HPA activity. Thus, the reduction in leptin concentration observed in this study may have improved the regulation of HPA axis activity, promoting amelioration in depressive symptoms. Nonetheless, this hypothesis cannot be confirmed in the present investigation because it was not planned to assess HPA axis activity, although it should be addressed in future studies. Additionally, Antonijevic et al. [2] pointed out that leptin inhibits NPY release from the neurons in the hypothalamus, which might contribute to the symptoms observed in depression, since NPY stimulates food intake and reduces anxiety.
It is important to note that in the present study the multiple regression analysis showed that decreases in leptin concentrations during weight loss (and an assumed attenuation of leptin resistance) predicted improvement in depressive symptoms independently of body composition changes after long-term weight loss treatment. When the zBMI score was included in the regression model, it was observed that this variable shared with changes in leptin the role as predictor of decreased depressive symptoms after therapy. However, it is worth mentioning that zBMI it is not such an objective measure of adiposity as visceral fat or fat mass, for example, and this sharing role of zBMI score as an predictor of depressive symptoms could be related to psychosocial aspects on the etiology of depression, such as increased satisfaction in body image and quality of life after weight loss [6, 36] .
Nevertheless, in contrast, some studies have reported different results suggesting the role of adiposity on the leptin-depression relationship [38, 39, 41] , raising the need for further investigations to clarify these associations.
Further, although change in leptin concentration was a predictor of fewer depressive symptoms after therapy independent of gender (ˇ = 0.385; p = 0.002), when boys and girls were analyzed separately this result remained only for girls (ˇ = 0.545; p < 0.001), indicating that these associations may be stronger in girls than boys.
It is worth noting that on average girls had greater values of fat mass and leptin at baseline than boys, indicating a worse body composition and inflammatory profile in females. These results are consistent with previous findings that indicate higher fat mass and leptin levels in women than men [12, 19, 38, 56] . However, the absolute value of change was similar between boys and girls in both leptin concentrations and also in depression symptoms, which indicates that they improved similarly on these parameters. Even so, it was observed that the tested 'leptin-depression' hypothesis was confirmed only in girls, but not in boys, suggesting that gender may play an important role in leptin-predicted depressive symptoms.
Indeed, there is some previous evidence regarding gender differences in the relationship between leptin and depression [50] , although the data are not consistent. In agreement with the present study, Esel et al. [12] showed a positive correlation between leptin concentrations and severity of depression in women both before and also in longitudinal analyses after antidepressant treatment, which was not confirmed in men. Also, Antonijevic et al. [2] found a greater plasma leptin concentration in depressed females (but not males) when compared to controls. Häfner et al. [21] demonstrated a relationship between depressed mood and sleep disturbances and leptin levels in women but not in men. However, divergent data showed an increased risk for elevated leptin levels in healthy men with depressed mood and social isolation but not in women, as well as an association between depressed mood and social isolation with IL-6, another inflammatory marker, only in men [20] . On the other hand, Kraus et al. [29] , Jown et al. [27] and Yang et al. [56] have demonstrated lower levels of leptin in depressive disorder subjects compared to healthy controls. Moreover, Cizza et al. [8] and Deuschle et al. [11] have not found any associations between leptin and depression in men or women and OlszaneckaGlinianowicz et al. [44] have not found associations between leptin and depressive category in obese women.
It should be mentioned that the cited studies are mainly crosssectional and evaluate only adults. Moreover, the majority of studies evaluate depressive population, in contrast with the present investigation which evaluated depressive symptoms in an obese population. Hood et al. [22] showed that greater metabolic abnormalities, such as leptin, are associated with higher depressive categories in adolescents with diabetes, however, this was also a cross-sectional study and they did not test for gender differences.
Therefore, the present investigation presents a novel finding that may be helpful for the understanding of the role of leptin on the amelioration of depressive symptoms during weight loss in obese adolescents, especially in girls.
Some hypothesis can be raised to explain the gender differences, although data are not conclusive. Esel et al. [12] point out the HPA system hypothesis, on which the increase in leptin may be due to the HPA system hyperactivity and enhanced glucocorticoids, which stimulate gene expression and production of leptina independently of their effect on food intake. Therefore, they suggested that female adipose tissue might have a greater sensitivity to glucocorticoids, which may underlie the sexually dimorphic patter observed in the association between leptin and depression. This assumption helps explain such differences between girls and boys on the present investigation.
Lastly, it is known that the etiology of depression in women seems to be more complex than in men, with an important role of psychosocial events, such as social support and stressful life events [28, 33] . Thus, as was previously stated, mechanisms of stress regulations are suggested to play an important role in the association between leptin and depression. This sense, this gender differences in the etiology of depression may contribute to elucidate the differences found on the present investigation. Nevertheless, further research is needed to clarify these results.
In addition to its association with leptin and leptin/adiponectin ratio, the improvement in depressive symptoms was correlated with other important parameters of health and quality of life for obese individuals. Specifically, changes in depression correlated with changes in body mass, BMI, fat mass and subcutaneous fat, but also remained only for girls with exception for subcutaneous fat that also remained correlated in boys when analyzed separately. These results suggest an association between mental and physical health that need to be considered in the treatment of obese adolescents.
Moreover, as expected, changes in leptin concentrations showed positive correlations with changes in body mass and BMI, fat mass (% and kg), visceral fat, subcutaneous fat and leptin/adiponectin ratio. Inversely, leptin was negatively correlated with lean mass (%) and adiponectin/leptin ratio. This results are in agreement with previous ones that showed associations between weight loss and the improvement of body composition and the reduction of leptinemia [23, 31, 40] and also corroborate the hypothesis that hyperleptinemia plays an important role in pro-inflammatory status related to obesity, as previously demonstrated by Sanches et al. [51] . All together, these ameliorations are critical to the management of obesity-related diseases and demonstrate its relationships with the attenuation of hyperleptinemia, confirming the importance of leptin as a target for obesity treatment.
Lastly, it is important to emphasize that the results presented in this investigation are not intended to suggest that leptinemia is the exclusive cause of depression in the context of obesity. Depression is a multi-factorial and highly complex condition and it is not useful to reduce its etiology to a single cause. It is worth noting that, according to Carr et al. [6] , obese individuals report greater mistreatment in interpersonal relationships, such as disrespectful treatment, harassment or provocation, and obese status is often perceived as a flaw of character. In this way, obese individuals frequently endure stigmatizing experiences that promote body image dissatisfaction and depression.
Indeed, Markowitz et al. [36] propose that behavioral, cognitive and social mechanisms -functional impairment, repeated dieting, body image dissatisfaction, stigma, are likely to all play a role in the obesity-depression pathway. Moreover, they point out that the literature suggests some independent risk factors for comorbid obesity and depression, such as severity of obesity, female gender and high socioeconomic status.
Conclusion
In conclusion, the present investigation demonstrated that the reduction in leptin concentrations, and attenuation of leptinemia, is a predictor of the reduction in depressive symptoms in obese adolescents during weight loss, which appears to be independent from changes in anthropometric and body composition profile, especially in girls. Although there is evidence in the literature about the relationship between leptin and depression, no previous research has established this relationship in adolescents during weight loss therapy. Establishing a role for leptin in depression during long-term weight loss therapy may be valuable for identifying further targets for treatment. The present study involved a non-pharmacological treatment strategy based on lifestyle changes that can promote weight loss. However, the potential differences between pharmacological anti-depressive treatment and behavioral approaches to weight loss should be considered in future clinical treatments. Nevertheless, these results help to strengthen the hypothesis that leptinemia has an active role in depressive disorder. The present outcomes further clarify that a (pro-inflammatory) hyperleptinemic state is an important factor in understanding the association between weight loss and depression in obese adolescents.
